BioGaia Pharma AB
559114-8191ActiveDeveloping and out-licensing novel biotherapeutic platforms from microbiome research.
Oversigt
- 0
- Medarbejdere
- ≤1t SEK
- Omsætning
- 2017
- Grundlagt
Nøglebeslutningstagere
Staffan Strömberg
Board Member
Peter Rothschild
Chairman
Nigel Titford
CEO
Gianfranco Grompone
Vice President Discovery and Research at BioGaia AB
+3 flere kontakter i Funnelfeedr
Beskrivelse
BioGaia Pharma AB is a specialized biotechnology company founded in 2017 and based in Stockholm, Sweden. It operates as a subsidiary of the established BioGaia AB, leveraging extensive prior experience in probiotic and microbiome research. The core mission is driving the research and development of...
Tags
Nøgleord
Virksomhedsoplysninger
- Branche
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE559114819101
Beslutningstagere
7 kontakter i FunnelfeedrStaffan Strömberg
Board Member
Peter Rothschild
Chairman
Nigel Titford
CEO
Gianfranco Grompone
Vice President Discovery and Research at BioGaia AB
Peter D. Costantino
Board Member
Petra Jones Lierud
Development Director
Andre kontakter
Thomas J. Schnitzer
Professor
Lignende virksomheder
20 lignende virksomheder i FunnelfeedrInfant Bacterial Therapeutics AB
5–9 medarbejdereDeveloping novel biotherapeutics for premature infant diseases through rigorous clinical trials.
Biogaia New Sciences AB
1–4 medarbejdereLeading Swedish company developing scientifically validated probiotic products globally.
OxThera Intellectual Property AB
0 medarbejdereDeveloping novel biotherapies for rare kidney diseases like Primary Hyperoxaluria.
BioGaia AB
50–99 medarbejdereWorld leader developing and selling clinically proven probiotics for health.
OxThera AB
0 medarbejdereDeveloping novel biotherapies for rare kidney diseases like Primary Hyperoxaluria.
Udforsk mere
Spørgsmål om BioGaia Pharma AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo